Monday, August 31, 2026

Niu Technologies Stock Over 15% Up In The Last 5 Sessions

Niu Technologies Stock Over 15% Up In The Last 5 Sessions

(VIANEWS) - Shares of Niu Technologies (NASDAQ: NIU) rose by a staggering 15.67% in 5 sessions from $3.51 at 15.67, to $4.06 at 20:22 EST on Tuesday, after three successive sessions in a row of gains. NASDAQ is rising 0.36% to $13,276.42, following the last session's upward trend.

Niu Technologies's last close was $4.06, 57.71% below its 52-week high of $9.60.

About Niu Technologies

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.16.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -6.41%.

Volume

Today's last reported volume for Niu Technologies is 393386 which is 44.15% below its average volume of 513887.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Niu Technologies's stock is considered to be oversold (<=20).

Volatility

Niu Technologies's last week, last month's, and last quarter's current intraday variation average was 0.79%, 0.25%, and 3.00%.

Niu Technologies's highest amplitude of average volatility was 3.35% (last week), 3.97% (last month), and 3.00% (last quarter).

Yearly Top and Bottom Value

Niu Technologies's stock is valued at $4.06 at 20:22 EST, way below its 52-week high of $9.60 and way higher than its 52-week low of $2.57.

More news about Niu Technologies (NIU).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com